These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20980466

  • 1. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Vigneri R, Sava L, Squatrito S, Sciacca L.
    Diabetes; 2010 Nov; 59(11):e24. PubMed ID: 20980466
    [No Abstract] [Full Text] [Related]

  • 2. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Simon D, Balkau B.
    Diabetes; 2010 Nov; 59(11):e25. PubMed ID: 20980467
    [No Abstract] [Full Text] [Related]

  • 3. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Carstensen B.
    Diabetes; 2010 Sep; 59(9):e17-8; author reply e19-22. PubMed ID: 20805379
    [No Abstract] [Full Text] [Related]

  • 4. Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.
    Yang X, So WY, Ma RC, Kong AP, Xu G, Chan JC.
    Diabetes Metab Res Rev; 2012 Jul; 28(5):379-87. PubMed ID: 22318884
    [Abstract] [Full Text] [Related]

  • 5. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
    Yang X, Ko GT, So WY, Ma RC, Yu LW, Kong AP, Zhao H, Chow CC, Tong PC, Chan JC.
    Diabetes; 2010 May; 59(5):1254-60. PubMed ID: 20185812
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of hyperglycemia and cancer risk: response to Stattin et al.
    Bowker SL, Johnson JA.
    Diabetes Care; 2007 Jul; 30(7):e77; author reply e78. PubMed ID: 17596500
    [No Abstract] [Full Text] [Related]

  • 7. Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings--what, why and how?
    Yang XL, Ma RC, So WY, Kong AP, Xu G, Chan JC.
    Diabetes Obes Metab; 2012 Jul; 14(7):579-85. PubMed ID: 22171706
    [Abstract] [Full Text] [Related]

  • 8. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry.
    So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC.
    Diabetes Metab Res Rev; 2008 Jul; 24(3):238-46. PubMed ID: 17992700
    [Abstract] [Full Text] [Related]

  • 9. Sense of coherence amongst Hong Kong Chinese adults with insulin-treated type 2 diabetes.
    Shiu AT.
    Int J Nurs Stud; 2004 May; 41(4):387-96. PubMed ID: 15050850
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H.
    Duodecim; 1999 May; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract] [Full Text] [Related]

  • 11. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug 24; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utilization of antidiabetic drugs in Hong Kong: relation to the common occurrence of antidiabetic drug-induced hypoglycemia amongst acute medical admissions and the relative prevalence of NIDDM.
    Chan TY, Lee KK, Chan AW, Critchley JA.
    Int J Clin Pharmacol Ther; 1996 Jan 24; 34(1):43-6. PubMed ID: 8688996
    [Abstract] [Full Text] [Related]

  • 14. Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease.
    Gude AB, Christiansen JS.
    Expert Opin Pharmacother; 2010 Jun 24; 11(9):1603-4; author reply 1604. PubMed ID: 20367274
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K, Staiger H, Kantartzis K, Fritsche A, Kanz L, Häring HU.
    Dtsch Med Wochenschr; 2010 May 24; 135(18):924-9. PubMed ID: 20425680
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Implications of the diabetes control and complications trial. American Diabetes Association.
    J Fla Med Assoc; 1998 Aug 24; 85(2):22-4. PubMed ID: 9782715
    [No Abstract] [Full Text] [Related]

  • 20. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R, Müller UA, Braun A, Stein G, Kath R.
    Eur J Med Res; 2005 Aug 17; 10(8):339-44. PubMed ID: 16131475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.